All
The Poetics of Prosthetic Bras
May 23rd 2018Even if being asymmetrical or flat is a valid choice for women who have undergone mastectomies, and that is how I usually feel best, there are no rules that say we should not wear a prosthetic bra now and then, or every single day, if it makes us smile or forget for a fleeting second that cancer can be disfiguring. There is no reason to feel self-conscious.
Patients and Caregivers Are on the 'Frontline' of Melanoma Monitoring
May 22nd 2018Recent research, conducted at NYU Langone Health and presented at the Oncology Nursing Society (ONS) Annual Congress, sought to find out how patients with melanoma perceived skin health education, and their willingness be involved in their own surveillance or a loved one’s.
Join the Conversation About Oncology Nurses
May 21st 2018Oncology nurses are on the front line of patient care, and last week, at the Oncology Nursing Society (ONS) Annual Congress, we reported on the ever-growing nursing role and recent research coming out in how they can more effectively treat patients with cancer.
Technology May Decrease Symptom Burden in Head and Neck Cancer Survivors
May 21st 2018Patients with head and neck cancer experienced a decrease in symptom severity after using mobile and sensor technology that allowed their health care providers to remotely monitor symptoms, according to research that will be presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.
Navigating the Waves of Cancer Treatment
May 17th 2018In this week’s episode of CURE Talks Cancer, we spoke with Matt Lashey, creator and CEO of the chemoWave app, which is designed to manage cancer symptoms and conditions by keeping track of a patient’s overall well-being to understand how their experiences may be related to feeling better or worse during treatment.
Genomic Analysis Points to More Effective Treatment Options in Lymphoma Subtype
May 15th 2018Thanks to genomic analysis by scientists at the Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard, diffuse large B cell lymphoma (DLBCL) is now a little easier to understand – and possibly easier to treat.